Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

OBJECTIVE: Lipoprotein(a) (Lp(a)) is an important genetically determined risk factor for atherosclerotic vascular disease (ASCVD). With the development of Lp(a)-lowering therapies, this study sought to characterise patterns of Lp(a) levels in a global ASCVD population and identify racial, ethnic, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Nissen, Steven E, Wolski, Kathy, Cho, Leslie, Nicholls, Stephen J, Kastelein, John, Leitersdorf, Eran, Landmesser, Ulf, Blaha, Michael, Lincoff, A Michael, Morishita, Ryuichi, Tsimikas, Sotirios, Liu, Junhao, Manning, Brian, Kozlovski, Plamen, Lesogor, Anastasia, Thuren, Tom, Shibasaki, Taro, Matei, Florin, Silveira, Fábio Serra, Meunch, Andreas, Bada, Aysha, Vijan, Vinod, Bruun, Niels Eske, Nordestgaard, Borge G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577925/
https://www.ncbi.nlm.nih.gov/pubmed/36252994
http://dx.doi.org/10.1136/openhrt-2022-002060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577925/
https://www.ncbi.nlm.nih.gov/pubmed/36252994
http://dx.doi.org/10.1136/openhrt-2022-002060

Ejemplares similares